ArticleJournal of translational medicine2025

Knockout IL4I1 affects macrophages to improve poor efficacy of CD19 CAR-T combined with PD-1 inhibitor in relapsed/refractory diffuse large B-cell lymphoma.

Rui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.